| scholarly article | Q13442814 |
| P50 | author | Francis Atkinson | Q60651741 |
| Anna Gaulton | Q28946674 | ||
| John P. Overington | Q30104439 | ||
| George Papadatos | Q33035163 | ||
| Louisa Bellis | Q43370917 | ||
| Nathan Dedman | Q47474720 | ||
| P2093 | author name string | Mark Davies | |
| Michał Nowotka | |||
| P2860 | cites work | MyChEMBL: A Virtual Platform for Distributing Cheminformatics Tools and Open Data | Q54152491 |
| ChEMBL Beaker: A Lightweight Web Framework Providing Robust and Extensible Cheminformatics Services | Q56915983 | ||
| BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities | Q24675698 | ||
| Basic local alignment search tool | Q25938991 | ||
| The Chemistry Development Kit (CDK): an open-source Java library for Chemo- and Bioinformatics | Q27061829 | ||
| The ChEMBL bioactivity database: an update | Q27144224 | ||
| Description of several chemical structure file formats used by computer programs developed at Molecular Design Limited | Q27783587 | ||
| SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules | Q28090714 | ||
| The Taverna workflow suite: designing and executing workflows of Web Services on the desktop, web or in the cloud | Q28290043 | ||
| The EBI RDF platform: linked open data for the life sciences | Q28305672 | ||
| ChEMBL: a large-scale bioactivity database for drug discovery | Q28315179 | ||
| myChEMBL: a virtual machine implementation of open data and cheminformatics tools | Q28660596 | ||
| PubChem: a public information system for analyzing bioactivities of small molecules | Q28842768 | ||
| PubChem's BioAssay Database | Q34090643 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | W1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | web service | Q193424 |
| drug discovery | Q1418791 | ||
| data sharing | Q5227350 | ||
| ChEMBL | Q6120337 | ||
| P304 | page(s) | W612-20 | |
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | Nucleic Acids Research | Q135122 |
| P1476 | title | ChEMBL web services: streamlining access to drug discovery data and utilities | |
| P478 | volume | 43 |
| Q92017254 | A Fragment Library of Natural Products and its Comparative Chemoinformatic Characterization |
| Q124670540 | A Sample-Centric and Knowledge-Driven Computational Framework for Natural Products Drug Discovery |
| Q91556269 | A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer |
| Q102371658 | A ligand-based computational drug repurposing pipeline using KNIME and Programmatic Data Access: case studies for rare diseases and COVID-19 |
| Q112640511 | A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell lines |
| Q55499060 | A novel methodology on distributed representations of proteins using their interacting ligands. |
| Q92335889 | Accessing public compound databases with KNIME |
| Q91998724 | Advancing Drug Discovery via Artificial Intelligence |
| Q114872003 | An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters |
| Q91367495 | Applications of Deep-Learning in Exploiting Large-Scale and Heterogeneous Compound Data in Industrial Pharmaceutical Research |
| Q96771342 | BPA and its analogues (BPS and BPF) modify the expression of genes involved in the endocrine pathway and apoptosis and a multi drug resistance gene of the aquatic midge Chironomus riparius (Diptera) |
| Q90743436 | Big Data Challenges Targeting Proteins in GPCR Signaling Pathways; Combining PTML-ChEMBL Models and [35S]GTPγS Binding Assays |
| Q31130953 | Big Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials |
| Q112176855 | COVID-19 and cardiovascular complications - preliminary results of the LATE-COVID study |
| Q50061336 | Caenorhabditis elegans: nature and nurture gift to nematode parasitologists |
| Q104797445 | Can natural products stop the SARS-CoV-2 virus? A docking and molecular dynamics study of a natural product database |
| Q93154732 | Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use |
| Q58608307 | ChEMBL: towards direct deposition of bioassay data |
| Q102328553 | ChemBoost: A chemical language based approach for protein - ligand binding affinity prediction |
| Q91801980 | Chemi-Net: A Molecular Graph Convolutional Network for Accurate Drug Property Prediction |
| Q112280555 | Chemical Interrogation of Nuclear Size Identifies Compounds with Cancer Cell Line-Specific Effects on Migration and Invasion |
| Q91892697 | Cheminformatics Analysis and Modeling with MacrolactoneDB |
| Q92420815 | Comparison of Target Features for Predicting Drug-Target Interactions by Deep Neural Network Based on Large-Scale Drug-Induced Transcriptome Data |
| Q94540905 | CompoundDB4j: Integrated drug resource of heterogeneous chemical databases |
| Q112580786 | Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 MPRO |
| Q90788235 | Computational Investigation of Drug Phototoxicity: Photosafety Assessment, Photo-Toxophore Identification, and Machine Learning |
| Q38715258 | Computational methods to identify metabolic sub-networks based on metabolomic profiles. |
| Q102152609 | Current Challenges and Opportunities in Designing Protein-Protein Interaction Targeted Drugs |
| Q38837677 | Current situation and future usage of anticancer drug databases |
| Q42697768 | Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR. |
| Q58592847 | Deep Confidence: A Computationally Efficient Framework for Calculating Reliable Prediction Errors for Deep Neural Networks |
| Q91782845 | Deep learning of pharmacogenomics resources: moving towards precision oncology |
| Q91061830 | Discovering Highly Potent Molecules from an Initial Set of Inactives Using Iterative Screening |
| Q91642873 | Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening |
| Q36229209 | Discovery of novel dual VEGFR2 and Src inhibitors using a multistep virtual screening approach |
| Q64082229 | Diverse Isoquinoline Scaffolds by Ugi/Pomeranz-Fritsch and Ugi/Schlittler-Müller Reactions |
| Q48280219 | DockBench as docking selector tool: the lesson learned from D3R Grand Challenge 2015. |
| Q90722338 | DockNmine, a Web Portal to Assemble and Analyse Virtual and Experimental Interaction Data |
| Q112646143 | Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs |
| Q98653355 | Dynamic-shared pharmacophore approach as tool to design new allosteric PRC2 inhibitors, targeting EED binding pocket |
| Q96644332 | Dynamics and conformational propensities of staphylococcal CntA |
| Q112294854 | Functional alterations by a subgroup of neonicotinoid pesticides in human dopaminergic neurons |
| Q91198523 | FungiPAD: A Free Web Tool for Compound Property Evaluation and Fungicide-Likeness Analysis |
| Q104059988 | GPCRdb in 2021: integrating GPCR sequence, structure and function |
| Q114369129 | GenUI: interactive and extensible open source software platform for de novo molecular generation and cheminformatics |
| Q28606551 | Geroprotectors.org: a new, structured and curated database of current therapeutic interventions in aging and age-related disease |
| Q91984984 | Hydroxyl Groups in Synthetic and Natural-Product-Derived Therapeutics: A Perspective on a Common Functional Group |
| Q110741727 | IFPTML Mapping of Drug Graphs with Protein and Chromosome Structural Networks vs. Pre-Clinical Assay Information for Discovery of Antimalarial Compounds |
| Q112639213 | Identification of HMGCR as the anticancer target of physapubenolide against melanoma cells by in silico target prediction |
| Q92874098 | Identification of the potential biological target of N-benzenesulfonyl-1,2,3,4-tetrahydroquinoline compounds active against gram-positive and gram-negative bacteria |
| Q90104058 | In silico identification of novel 5-HT2A antagonists supported with ligand- and target-based drug design methodologies |
| Q38689965 | In silico methods to address polypharmacology: current status, applications and future perspectives |
| Q91191273 | In-Silico Molecular Binding Prediction for Human Drug Targets Using Deep Neural Multi-Task Learning |
| Q39892203 | Introduction to Cheminformatics |
| Q40397851 | KLIFS: a structural kinase-ligand interaction database |
| Q100756336 | KLIFS: an overhaul after the first 5 years of supporting kinase research |
| Q92891204 | KekuleScope: prediction of cancer cell line sensitivity and compound potency using convolutional neural networks trained on compound images |
| Q28829862 | Kinetic barriers in the isomerization of substituted ureas: implications for computer-aided drug design |
| Q31141722 | Knowledge Representation and Management: a Linked Data Perspective |
| Q98567577 | Large-Scale Assessment of Binding Free Energy Calculations in Active Drug Discovery Projects |
| Q97093054 | Linking protein to phenotype with Mendelian Randomization detects 38 proteins with causal roles in human diseases and traits |
| Q113331196 | Marine Biodiscovery in a Changing World |
| Q57265612 | MetaboRank: network-based recommendation system to interpret and enrich metabolomics results |
| Q111508027 | Metabolic Footprinting of Microbial Systems Based on Comprehensive In Silico Predictions of MS/MS Relevant Data |
| Q98306012 | Modeling the metabolic interplay between a parasitic worm and its bacterial endosymbiont allows the identification of novel drug targets |
| Q112063050 | MolData, a molecular benchmark for disease and target based machine learning |
| Q90982274 | Mushroom Tyrosinase-Based Enzyme Inhibition Assays Are Not Suitable for Bioactivity-Guided Fractionation of Extracts |
| Q92415915 | N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification |
| Q92602221 | Network Pharmacology Identifies the Mechanisms of Action of Shaoyao Gancao Decoction in the Treatment of Osteoarthritis |
| Q47762603 | Novel FXa Inhibitor Identification through Integration of Ligand- and Structure-Based Approaches. |
| Q91634958 | Novel Opioids: Systematic Web Crawling Within the e-Psychonauts' Scenario |
| Q64106645 | Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics |
| Q114868908 | Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2 |
| Q90762623 | Open-Access Activity Prediction Tools for Natural Products. Case Study: hERG Blockers |
| Q99556426 | PTML Multi-Label Algorithms: Models, Software, and Applications |
| Q89679945 | Pose Filter-Based Ensemble Learning Enables Discovery of Orally Active, Nonsteroidal Farnesoid X Receptor Agonists |
| Q94566933 | Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease |
| Q98201905 | Prediction of Antimalarial Drug-Decorated Nanoparticle Delivery Systems with Random Forest Models |
| Q62112530 | Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets |
| Q112577136 | QSAR based virtual screening derived identification of a novel hit as a SARS CoV-229E 3CLpro Inhibitor: GA-MLR QSAR modeling supported by molecular Docking, molecular dynamics simulation and MMGBSA calculation approaches |
| Q102069261 | Rational Drug Design for Pseudomonas aeruginosa PqsA Enzyme: An in silico Guided Study to Block Biofilm Formation |
| Q91556088 | Rational design, synthesis and biological profiling of new KDM4C inhibitors |
| Q97426723 | Recommender Systems in Antiviral Drug Discovery |
| Q93044121 | Reliable Prediction Errors for Deep Neural Networks Using Test-Time Dropout |
| Q98288107 | Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis |
| Q90505337 | Research update and opportunity of non-hormonal male contraception: Histone demethylase KDM5B-based targeting |
| Q56992819 | Review and comparative assessment of similarity-based methods for prediction of drug–protein interactions in the druggable human proteome |
| Q112574166 | ScaffComb: A Phenotype-Based Framework for Drug Combination Virtual Screening in Large-Scale Chemical Datasets |
| Q36350419 | Scaffold Diversity of Fungal Metabolites |
| Q38695331 | Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery. |
| Q90257724 | Shape Similarity by Fractal Dimensionality: An Application in the de novo Design of (-)-Englerin A Mimetics |
| Q64929938 | Shared Molecular Signatures Across Neurodegenerative Diseases and Herpes Virus Infections Highlights Potential Mechanisms for Maladaptive Innate Immune Responses. |
| Q30389067 | Structural database resources for biological macromolecules |
| Q46582575 | Structure-Based Design and Discovery of New M2 Receptor Agonists |
| Q58079602 | Survey of Similarity-based Prediction of Drug-protein Interactions |
| Q94551816 | TF3P: A New Three-dimensional Force Fields Fingerprint Learned by Deep Capsular Network |
| Q64067149 | TeachOpenCADD: a teaching platform for computer-aided drug design using open source packages and data |
| Q28818109 | The BioGRID interaction database: 2017 update |
| Q28584450 | The ChEMBL database in 2017 |
| Q91876069 | The Effect of Debiasing Protein-Ligand Binding Data on Generalization |
| Q38875819 | The MIntAct Project and Molecular Interaction Databases. |
| Q110391814 | The Natural Products Atlas 2.0: a database of microbially-derived natural products |
| Q89962804 | The e-Psychonauts' 'Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available Online |
| Q38731960 | The recent progress in proteochemometric modelling: focusing on target descriptors, cross-term descriptors and application scope. |
| Q47104996 | The secondary metabolite bioinformatics portal: Computational tools to facilitate synthetic biology of secondary metabolite production. |
| Q98158434 | Trapping conformational states of a flavin-dependent N-monooxygenase in crystallo reveals protein and flavin dynamics |
| Q89931335 | User guide for the discovery of potential drugs via protein structure prediction and ligand docking simulation |
| Q36397674 | Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery. |
| Q38836168 | Using reverse docking for target identification and its applications for drug discovery |
| Q91703700 | Validation Study of QSAR/DNN Models Using the Competition Datasets |
| Q28269956 | WormBase 2016: expanding to enable helminth genomic research |
| Q36435078 | iPPI-DB: an online database of modulators of protein-protein interactions. |
Search more.